Cargando…
Prolonged Regression of Metastatic Leptomeningeal Breast Cancer That Has Failed Conventional Therapy: A Case Report and Review of the Literature
Approximately 5% of breast cancer patients develop leptomeningeal metastases over the course of their disease. Though several treatments options are available for these patients, their prognosis is typically considered to be poor. We report a case of leptomeningeal failure after a patient underwent...
Autores principales: | Vincent, Andrew, Lesser, Glenn, Brown, Doris, Vern-Gross, Tamara, Metheny-Barlow, Linda, Lawrence, Julia, Chan, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625760/ https://www.ncbi.nlm.nih.gov/pubmed/23593093 http://dx.doi.org/10.4048/jbc.2013.16.1.122 |
Ejemplares similares
-
Metastatic Melanoma With Leptomeningeal Disease
por: Marinova, Amanda M., et al.
Publicado: (2021) -
Has Pasteur Failed?
Publicado: (1890) -
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report
por: Kim, Dae Won, et al.
Publicado: (2015) -
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
por: Stenberg, Daniel, et al.
Publicado: (2021) -
Treatment of Leptomeningeal Carcinomatosis in a Patient With Metastatic Cholangiocarcinoma
por: Jacobs, Ramon E.A., et al.
Publicado: (2014)